C R Divgi

1.2k total citations
11 papers, 581 citations indexed

About

C R Divgi is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, C R Divgi has authored 11 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Radiology, Nuclear Medicine and Imaging, 6 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in C R Divgi's work include Radiopharmaceutical Chemistry and Applications (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Peptidase Inhibition and Analysis (3 papers). C R Divgi is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Peptidase Inhibition and Analysis (3 papers). C R Divgi collaborates with scholars based in United States, Netherlands and Italy. C R Divgi's co-authors include Steven M. Larson, Ronald D. Finn, S Welt, E A Carswell, Andrew M. Scott, Lloyd J. Old, Martin C. Graham, Alfred Cohen, Pilar Garin‐Chesa and J. Mendelsohn and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and International Journal of Oncology.

In The Last Decade

C R Divgi

11 papers receiving 570 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C R Divgi United States	10	307	247	205	150	114	11	581
Jotaro Hata Japan	9	416 1.4×	110 0.4×	283 1.4×	209 1.4×	91 0.8×	14	773
M. Bennett United Kingdom	3	295 1.0×	107 0.4×	218 1.1×	113 0.8×	96 0.8×	5	590
W. H. Miller United States	9	486 1.6×	104 0.4×	283 1.4×	166 1.1×	88 0.8×	17	723
J. Baselga Spain	10	399 1.3×	98 0.4×	312 1.5×	139 0.9×	188 1.6×	25	649
Dan Lu China	9	203 0.7×	94 0.4×	458 2.2×	85 0.6×	131 1.1×	16	694
Nicholas Murray United Kingdom	10	168 0.5×	56 0.2×	224 1.1×	94 0.6×	53 0.5×	19	669
Oscar B. Goodman United States	16	385 1.3×	181 0.7×	405 2.0×	528 3.5×	335 2.9×	33	1.0k
Henry Koo United States	5	237 0.8×	156 0.6×	538 2.6×	86 0.6×	186 1.6×	6	731
Stephan Tschirdewahn Germany	16	197 0.6×	96 0.4×	234 1.1×	269 1.8×	159 1.4×	57	677
Harm Westdorp Netherlands	14	439 1.4×	102 0.4×	175 0.9×	140 0.9×	112 1.0×	43	696

Countries citing papers authored by C R Divgi

Since Specialization

Citations

This map shows the geographic impact of C R Divgi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C R Divgi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C R Divgi more than expected).

Fields of papers citing papers by C R Divgi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C R Divgi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C R Divgi. The network helps show where C R Divgi may publish in the future.

Co-authorship network of co-authors of C R Divgi

This figure shows the co-authorship network connecting the top 25 collaborators of C R Divgi. A scholar is included among the top collaborators of C R Divgi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C R Divgi. C R Divgi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Freeby, Matthew, P. Kringas, Robin Goland, et al.. (2015). Cross-sectional and Test-Retest Characterization of PET with [18F]FP-(+)-DTBZ for β Cell Mass Estimates in Diabetes. Molecular Imaging and Biology. 18(2). 292–301. 18 indexed citations

Coit, Daniel G., David H. Ilson, Joseph Randazzo, et al.. (2007). A phase II study of preoperative chemotherapy with irinotecan(CPT) and cisplatin(CIS) for gastric cancer(NCI 5917): FDG-PET/CT predicts patient outcome. Journal of Clinical Oncology. 25(18_suppl). 4502–4502. 25 indexed citations

Krug, Lee M., Daniel T. Milton, Achim A. Jungbluth, et al.. (2006). Targeting Lewis Y (LeY) in small cell lung cancer (SCLC) with a humanized monoclonal antibody, hu3S193. Journal of Clinical Oncology. 24(18_suppl). 7086–7086. 2 indexed citations

Berg, William J., C R Divgi, David M. Nanus, & Robert J. Motzer. (2000). Novel investigative approaches for advanced renal cell carcinoma.. PubMed. 27(2). 234–9. 22 indexed citations

Barendswaard, E, Andrew M. Scott, C R Divgi, et al.. (1998). Rapid and specific targeting of monoclonal antibody A33 to a colon cancer xenograft in nude mice.. International Journal of Oncology. 12(1). 45–53. 21 indexed citations

Divgi, C R. (1996). Status of radiolabeled monoclonal antibodies for diagnosis and therapy of cancer.. PubMed. 10(6). 939–53; discussion 954, 957. 23 indexed citations

Divgi, C R, Andrew M. Scott, Elizabeth K. Broussard, et al.. (1995). Pilot radioimmunotherapy trial with 131I-labeled murine monoclonal antibody CC49 and deoxyspergualin in metastatic colon carcinoma.. PubMed. 1(12). 1503–10. 19 indexed citations

Welt, S, C R Divgi, Andrew M. Scott, et al.. (1994). Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts.. Journal of Clinical Oncology. 12(6). 1193–1203. 205 indexed citations

Oosterwijk, Egbert, Neil H. Bander, C R Divgi, et al.. (1993). Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250.. Journal of Clinical Oncology. 11(4). 738–750. 141 indexed citations

10.

Divgi, C R & Steven M. Larson. (1989). Radiolabeled monoclonal antibodies in the diagnosis and treatment of malignant melanoma. Seminars in Nuclear Medicine. 19(4). 252–261. 24 indexed citations

11.

Goldenberg, Alec, et al.. (1989). Imaging of Human Tumor Xenografts With an Indium-111-Labeled Anti-Epidermal Growth Factor Receptor Monoclonal Antibody. JNCI Journal of the National Cancer Institute. 81(21). 1616–1625. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact